Companies and Markets
Market Research A to Z | Company Profiles A to Z | Register | Contact Us
+44 (0) 203 086 8600 Call us on

The Pharmaceutical Excipients Market Outlook

2278.32

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,278.32

Change Currency

GBP EURO USD

Market

Healthcare and Medical

Report Type

Market Research

Country

Global

Published

19 January 2011

Number of Pages

86

Report Delivery

Email

Delivery Lead Time

1-3 hours, 24 hour max

Publisher

Business Insights

File Format

-

The Pharmaceutical Excipients Market Outlook - The established markets, including the US, UK, and Japan, together account for 30% of the global demand for excipients. The US recorded the largest single demand for pharmaceutical excipients, representing 15.9% of the global demand in 2009. Diluents formed the biggest category. We expect the global excipients demand by volume to grow at a CAGR of 4.9% during 2009–15. The established markets, including the US, UK and Japan, will demonstrate a growth of 3.8% whereas the emerging markets especially China, India and Brazil will grow at a faster pace of 6.3%.

Advances in nanotechnology have redefined excipients, imparting new functions to them. An excipient can also act as a carrier of drug particles that are coated on it using nanotechnology for improved stability and release. Combination excipients are increasingly being used by formulators as they bypass regulatory and processing hurdles.

The pharmaceutical excipients market has seen tremendous developments in recent times. Pharmaceutical excipients are increasingly being considered as functional ingredients in contrast to their earlier status as non-functional additives. Consequently, drug product manufacturers are now seeking novel, value-added excipients for new product development.

Features and benefits

* Gain a detailed understanding of the major types of pharmaceutical excipients used, including market sizing and forecasts to 2015.
* Learn from profiles of the leading players in the pharmaceutical excipients market and gain an insight into their key products.
* Assess innovations in pharmaceutical excipients that will shape the future of the market.
* Understand the regulatory environment affecting the pharmaceutical excipients market and influencing the introduction of new products.
* Gain an overview of the most important recent deals, alliances, collaborations, mergers, and acquisitions in the pharmaceutical excipients market.

Your key questions answered

* Whjat will be the largest growth opportunities in the pharmaceutical excipients market?
* What are the key drivers and resistors that will effect the growth of the pharmaceutical excipients market?
* Who are the key players in the excipients market?
* What are the new advances in pharmaceutical excipients and which of the advances offer significant potential in the future?
* What are the key regulations that impact the pharmaceutical excipients market?

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

Electronic License

Electronic License

An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.

Site License

Site License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.

Corporate License

Corporate License

An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£2,278.32

Change Currency

GBP EURO USD

Visitor Comments

All posts are pre-moderated and must obey the house rules.

Change Currency

GBP
USD

Use our research skills: Get free support

Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support

eBrandPromote: Get your brands ranked highly online

eBrandPromote: Let us promote your brand online through article writing, press release distribution, social media and search engine marketing services. Click here to download our eBrandPromote brochure.

Accessibility
Close

Contrast settings

Text size settings